Cardiovascular and Renal Drugs Advisory Committee (CRDAC) in Joint Session with the Drug Safety and Risk Management Advisory Committee (DSaRM)

September 11, 2007

SLIDES

Dwaine Rieves, M.D., CDER, FDA (ppt) (html)

Guest Speakers Presentations

Ajay K. Singh, M.D., (ppt) (html)

Dennis Cotter, M.S.E., Miguel Herman, M.D., and Yi Zhang, D.D.S., (ppt) (html)

Sponsor Presentations

Marc Pfeffer, M.D., Ph.D. (ppt) (pdf)

Paul Eisenberg, M.D., M.P.H., F.A.C.C., (ppt) (pdf)

Allen R. Nissenson, M.D., F.A.C.P., F.A.S.N., (ppt) (pdf)

Preston Klassen, M.D., M.H.S., (ppt) (pdf)

Paul Eisenberg, M.D., M.P.H., F.A.C.C., (ppt) (pdf)

FDA Presentations

Ann Marie Trentacosti, M.D., (ppt) (html)

Ellis F. Unger, M.D., (ppt) (html)

Open Public Hearing Presentations

Jonathan Himmelfarb, MD & Lynda Anne Szczech, MD, MSCE, FASN, American Society of Nephrology (ppt) (html)

Friedrich Port, Ph.D and Robert Wolfe, Ph.D, Arbor Research Collaborative for Health (ppt) (html)

Robert Provenzano, M.D, FACP, FASN, Davita Inc. (ppt) (html)

Michael Lazarus, M.D, Fresenius Medical Care North America (ppt) (html)

David Van Wyck, M.D, National Kidney Foundation (ppt) (html)

---

Up | AC Home Page